Windlas Biotech IPO Review | Windlas Biotech Business Model | Apply or Avoid Windlas Biotech IPO
Note – The price band of Windlas Biotech is ranged from Rs 448 – 460. All the data is been taken from DRHP instead of RHP. Also, while making this video, the GMP data wasn’t available.
(As per 29th July)
Windlas Biotech Ltd is amongst the top five players in the domestic pharmaceutical formulations contract development and manufacturing organization and is set to launch its IPO on 4th August. The company has a strong focus on the chronic therapeutic category. In this video, we will discuss all the important details related to the IPO, which will help you understand whether or not to apply for the IPO. The video includes –
Introduction
Company Profile
Strength
Risks
Object of Offer
Financials
********************************************************
Learn more about Windlas Biotech IPO – https://blog.finology.in/investing/windlas-biotech-ipo
********************************************************
Upcoming IPOs – https://ticker.finology.in/IPO/upcoming
Ticker Stock Screener – https://ticker.finology.in/screener
********************************************************
Open an investment account that suits your needs and get rewarded as well – https://select.finology.in
To open a Demat Account with Zerodha – https://zerodha.com/open-account?c=ZM…
*************************************************************
Your assistant in intelligent stock picking – https://ticker.finology.in
***************************************************************
Get in touch with us –
Twitter – https://twitter.com/finologyticker
Facebook Connect – https://www.facebook.com/finologyticker
Instagram Updates – https://www.instagram.com/finologyticker
Email – support@finology.in
Website – https://www.finology.in
#WindlasBiotechIPO #IPOReview #IPOdetailedanalysis
Note – The price band of Windlas Biotech is ranged from Rs 448 – 460. All the data is been taken from DRHP instead of RHP. Also, while making this video, the GMP data wasn’t available.
(As per 29th July)
Windlas Biotech Ltd is amongst the top five players in the domestic pharmaceutical formulations contract development and manufacturing organization and is set to launch its IPO on 4th August. The company has a strong focus on the chronic therapeutic category. In this video, we will discuss all the important details related to the IPO, which will help you understand whether or not to apply for the IPO. The video includes –
Introduction
Company Profile
Strength
Risks
Object of Offer
Financials
********************************************************
Learn more about Windlas Biotech IPO – https://blog.finology.in/investing/windlas-biotech-ipo
********************************************************
Upcoming IPOs – https://ticker.finology.in/IPO/upcoming
Ticker Stock Screener – https://ticker.finology.in/screener
********************************************************
Open an investment account that suits your needs and get rewarded as well – https://select.finology.in
To open a Demat Account with Zerodha – https://zerodha.com/open-account?c=ZM…
*************************************************************
Your assistant in intelligent stock picking – https://ticker.finology.in
***************************************************************
Get in touch with us –
Twitter – https://twitter.com/finologyticker
Facebook Connect – https://www.facebook.com/finologyticker
Instagram Updates – https://www.instagram.com/finologyticker
Email – support@finology.in
Website – https://www.finology.in
#WindlasBiotechIPO #IPOReview #IPOdetailedanalysis
About The Author
